The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

 

Neptune Technologies & Bioressources Inc

Nasdaq: NEPT
Last

(U.S.) $1.29

Today's change-0.05 -3.74%
Updated September 1 3:59 PM -4GMT. Delayed by at least 15 minutes.
 

Neptune Technologies & Bioressources Inc

Nasdaq: NEPT
Last

(U.S.) $1.29

Today's change-0.05 -3.74%
Updated September 1 3:59 PM -4GMT. Delayed by at least 15 minutes.

Neptune Technologies & Bioressources Inc down (U.S.)$0.05

Neptune Technologies & Bioressources Inc closed sharply lower Tuesday, dropping (U.S.)$0.05 or 3.74% to (U.S.)$1.29. Over the last five days, shares have gained 1.56%, but are down 32.11% for the last year to date. Shares have underperformed the S&P 500 by 28.70% during the last year.

Key company metrics

  • Open(U.S.) $1.34
  • Previous close(U.S.) $1.34
  • High(U.S.) $1.36
  • Low(U.S.) $1.27
  • Bid / Ask-- / --
  • YTD % change-32.11%
  • Volume56,209
  • Average volume (10-day)77,509
  • Average volume (1-month)95,673
  • Average volume (3-month)83,304
  • 52-week range(U.S.) $1.11 to (U.S.) $2.42
  • Beta1.01
  • Trailing P/ENegative, not meaningful
  • P/E 1 year forwardNegative, not meaningful
  • Forward PEGNegative, not meaningful
  • Indicated annual dividend--
  • Dividend yield0.00%
  • Trailing EPS(U.S.) -$0.37
Updated September 1 3:59 PM -4GMT. Delayed by at least 15 minutes.

Profit

Net Profit (TTM)
-216.00%

Although this company's net profit margin is negative, it is above the industry average and implies that Neptune Technologies & Bioressources Inc is operating more effectively than other companies in the industry.
Company Books

S&P TSX2.72%Sector:Industry:
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q1/2016Q4/2015Q3/2015Q2/2015
Fiscal Quarter Endvalues in $ millions unless otherwise notedMay 31, 201505/31/2015Feb 28, 201502/28/2015Nov 30, 201411/30/2014Aug 31, 201408/31/2014
Revenue3453
Total other revenue--------
Total revenue3453
Gross profit-1-50-4
Total cost of revenue4947
Total operating expense9151117
Selling / general / administrative4447
Research & development2333
Depreciation / amortization--------
Interest expense (income), net operating--------
Unusual expense (income)--0----
Other operating expenses, total0000
Operating income-6-11-6-14
Interest income (expense), net non-operating0------
Gain (loss) on sale of assets--------
Other--------
Income before tax-5-110-15
Income after tax-5-110-15
Income tax, total0000
Net income-4-9-1-13
Total adjustments to net income--------
Net income before extra. items-4-9-1-13
Minority interest11-12
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items-4-9-1-13
Inc. avail. to common incl. extra. items-4-9-1-13
Diluted net income-4-9-1-13
Dilution adjustment--0--0
Diluted weighted average shares75757575
Diluted EPS excluding extraordinary itemsvalue per share-0.06-0.12-0.02-0.17
Dividends per sharevalue per share0.000.000.000.00
Diluted normalized EPSvalue per share-0.06-0.12-0.02-0.17